While elevated circulating FABP4 levels are a potent biomarker for obesity, insulin resistance, T2DM, and cardiovascular disease (83, 84), the levels of FABP4 in AT either show a negative association with adiposity and insulin resistance or no association at all (85, 86). Here, FABP4 is linked to obesity disorder.